Clinical Trial Update: Intravenous High Dose NAC and Sodium Bicarbonate for the Prevention of Contrast-induced Acute Injury [NA]

View source ↗

Summary

A completed clinical trial evaluated intravenous high-dose N-acetylcysteine plus sodium bicarbonate for the prevention of contrast-induced acute kidney injury.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Contrast-induced Nephropathy
• Kidney Injury

Drugs mentioned

• N-acetylcysteine (N-acetylcysteine)
• Sodium Bicarbonate (sodium bicarbonate)

Snippet

Sponsor: Federal University of São Paulo | Conditions: Acute Renal Failure | NA | Status: COMPLETED